4BENGEL F M,PERMANETTER B,UNGERER M,et al.Relationship between altered sympathetic innervation,oxidative metabolism and contractile function in the cardiomyopathic human heart:a non-invasive study using positron emission tomography[J].Eur Heart J,2001,22:1594-1600.
5YOUNG A A,DOKOS S,POWELL K A,et al.Regional heterogeneity of function in nonischemic dilated cardiomyopathy[J].Cardiovasc Res,2001,49:308-318.
6KIVIKKO M,LEHTONEN L.Sustained hemodynamic effects of intravenous levosimendan[J].Circulation,2003,107:81-86.
7MATSUMURA S T,TSUSHIMA K,OHTAKI E,et al.Effects of carvedilol on plasma levels of IL-6 and TNF-2 in nine patients with dilated cardiomyopathy[J].J Cardiol,2002,39(5):253-257.
8OSTERZIEL K J,RANKE M B,STROHM O,et al.The Somatotrophic system in patients with dilated cardiomyoparhy:relation of insulin-like growth factor-1and its qlterations during growth hormone therapy to cardial function[J].Clin Endocri,2000,53(1):61-68.
9AHMET I,SAWA Y,IWATA K,et al.Gene transfection of hepatocyte growth factor attenuates cardial remodeling in the canine heart:a novel gene therapy for cardiomyopathy[J].J Thoracic Cardiovas Surg,2002,124(5):957-963.
10DORFFEL W,FELIX S,WALLUKAT G,et al.Short-term hemodynamic effects of immunoabsorption in dilated cardiomyopathy[J].Circulation,1997,95(8):1994-1997.
